Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study
| Autor: | Rosario Palacios MD, PhD, M. Mayorga MD, C. M. González-Domenech PhD, C. Hidalgo-Tenorio MD, PhD, C. Gálvez MD, PhD, L. Muñoz-Medina MD, J. de la Torre MD, PhD, A. Lozano MD, M. Castaño MD, M. Omar MD, PhD, Jesús Santos MD, PhD |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: | |
| Zdroj: | Journal of the International Association of Providers of AIDS Care, Vol 17 (2018) |
| Druh dokumentu: | article |
| ISSN: | 2325-9582 23259582 |
| DOI: | 10.1177/2325958218760847 |
| Popis: | Objectives: To analyze the efficacy and safety of dolutegravir/rilpivirine (DTG/RPV) in HIV-infected patients who switched from any other antiretroviral therapy (ART). Methods: Open-label, multicenter study including patients who switched to DTG/RPV between February 2015 and February 2016. Efficacy (HIV RNA |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|